In accordance with these observations, FGF21 has been found to prevent hepatic steatosis [4] and atherosclerosis [20] and, furthermore, it has been shown to have therapeutic potential against metabolic diseases, such as type 2 diabetes [21]. The gene discussed is FGF21; the disease is Hepatic steatosis.